Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.
Emergency Medicine December 4th 2024
Conexiant
Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.
Allergy & Immunology December 4th 2024
MDLinx
Phase 2a clinical trials demonstrate benfotiamine’s ability to enhance synaptic activity while maintaining an excellent safety profile, even at doses exceeding normal thiamine blood levels.
Family Medicine/General Practice December 4th 2024
Epoch Health
23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.
Endocrinology, Diabetes, Metabolism December 4th 2024
Alive
Probiotic therapy shows promise in managing thrush infections, even in cases resistant to conventional antifungal medications.
Family Medicine/General Practice November 27th 2024
Of 37 clinical questions examined by international experts, only 6 received clear evidence-based recommendations, highlighting significant gaps in UTI management evidence.